Related Experiment Video
Updated: May 4, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions
Michael Madigan1, Fateh Entabi1, Brian Zuckerbraun2
1Department of Veterans Affairs Medical Center, University of Pittsburgh, Pittsburgh, Pa; Division of Vascular Surgery, University of Pittsburgh, Pittsburgh, Pa.
Objective:
Intimal hyperplasia (IH) contributes to the failure of vascular interventions. While many investigational therapies inhibit the development of IH in animal models, few of these potential therapies can reverse established lesions. Inhaled carbon monoxide (CO) dramatically inhibits IH in both rats and pigs when given perioperatively. It also prevented the development of pulmonary arterial hypertension in rodents. Interestingly, CO could reverse pulmonary artery structural changes and right heart hemodynamic changes when administered after the establishment of pulmonary hypertension. Thus, we hypothesize that inhaled CO may mediate the regression of established neointimal lesions.
Methods:
Rats underwent carotid artery balloon angioplasty injury. Carotid arteries were collected at 2 and 4 weeks after injury for morphometric analysis of the neointima. Another group was treated with inhaled CO (250 parts per million) for 1 hour daily from week 2 until week 4. Additional rats were sacrificed 3 days after initiating CO treatment, and the carotid arteries were examined for apoptosis by terminal deoxynucleotidyl transferase dUTP nick end-labeling, proliferation by Ki67 staining, and autophagy by microtubule-associated protein light chain 3 I/II staining.
Results:
At 2 weeks following injury, sizable neointimal lesions had developed (intimal/media = 0.92 ± 0.22). By 4 weeks, lesion size remained stable (0.80 ± 0.09). Delayed inhaled CO treatment greatly reduced neointimal lesion size vs the 2- and 4-week control mice (0.38 ± 0.05; P < .05). Arteries from the CO-treated rats exhibited significantly reduced apoptosis compared with control vessels (3.18% ± 1.94% vs 16.26% ± 5.91%; P = .036). Proliferation was also dramatically reduced in the CO-treated animals (2.98 ± 1.55 vs 10.37 ± 2.80; P = .036). No difference in autophagy between control and CO-treated rats was detected.
Conclusions:
Delayed administration of inhaled CO reduced established neointimal lesion size. This effect was mediated by the antiproliferative effect of CO on medial and intimal smooth muscle cells without increases in arterial wall apoptosis or autophagy. Future studies will examine additional time points to determine if there is temporal variation in the rates of apoptosis and autophagy.
Insights
Inhaled carbon monoxide (CO) effectively reduces established intimal hyperplasia lesions by inhibiting smooth muscle cell proliferation. This study demonstrates CO
Area of Science:
- Vascular biology and regenerative medicine
- Cardiovascular research
- Pharmacology of inhaled gases
Background:
- Intimal hyperplasia (IH) is a major cause of vascular intervention failure.
- Few therapies can reverse established IH lesions.
- Inhaled carbon monoxide (CO) shows promise in preventing and potentially reversing vascular changes.
Purpose of the Study:
- To investigate the efficacy of inhaled CO in regressing established neointimal lesions.
- To determine the cellular mechanisms underlying CO's effect on IH.
Main Methods:
- Rats underwent carotid artery balloon angioplasty.
- Inhaled CO treatment was administered from week 2 to week 4 post-injury.
- Neointima size, apoptosis, proliferation, and autophagy were analyzed.
Main Results:
- Delayed CO treatment significantly reduced established neointimal lesion size.
- CO treatment markedly decreased smooth muscle cell proliferation.
- Apoptosis and autophagy levels were not significantly increased by CO treatment.
Conclusions:
- Inhaled CO can mediate the regression of established neointimal lesions.
- The antiproliferative effect on smooth muscle cells is the primary mechanism.
- CO offers a potential therapeutic strategy for vascular proliferative diseases.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

